Enterotoxigenic Escherichia coli (ETEC), a heterogeneous diarrheal pathovar defined by 33 production of heat-labile (LT) and/or heat-stable (ST) toxins, remain major causes of mortality 34 among children in developing regions, and cause substantial morbidity in individuals living in or 35 traveling to endemic areas. Studies demonstrating a major burden of ST-producing ETEC have 36 focused interest on ST toxoids for ETEC vaccines. We therefore examined fundamental aspects 37 of ETEC ST biology using ETEC H10407, which carries estH and estP genes encoding ST-H and 38 ST-P, respectively, in addition to eltAB genes responsible for LT. In this background, we found 39 that deletion of estH significantly diminished cGMP activation in target epithelia, while deletion 40 of estP had a surprisingly modest impact, and a dual estH/estP mutant was not appreciably 41 different than the estH mutant. Nevertheless, either ST-H or ST-P recombinant peptides 42 stimulated cGMP production. We also found that the TolC efflux protein was essential for both 43 toxin secretion and delivery, providing a potential avenue for efflux inhibitors in treatment of 44 acute diarrheal illness. In addition, we demonstrated that the EtpA adhesin is required for 45 optimal delivery of ST and that antibodies against either the adhesin or ST-H significantly 46 impaired toxin delivery and cGMP activation in target T84 cells. Finally, we used FLAG epitope 47 fusions to demonstrate that the ST-H pro-peptide sequence is secreted by the bacteria, 48 potentially providing additional targets for antibody neutralization. These studies collectively 49 extend our understanding of ETEC pathogenesis and potentially inform additional avenues to 50 mitigate disease by these common diarrheal pathogens. 51 52 475
Diarrheal illnesses in low income countries continue to cause substantial morbidity and remain 56 one of the leading causes of death in young children in developing countries under the age of 57 five years. Among the bacterial causes of diarrheal illness enteroxigenic Escherichia coli (ETEC) 58 are commonly linked to more severe forms of illness in young children(1). These organisms are 59 perennially the most common cause of diarrhea in those who travel to endemic areas where 60 sanitation is poor(2, 3), however they have been identified repeatedly as the etiology of 61 diarrheal outbreaks and sporadic cases of illness in industrialized countries including the U.S(4-62 8). 63
Acute clinical presentations of ETEC infection may range from mild self-limited illness to severe 64 cholera-like diarrhea (9) (10) (11) . In addition, ETEC and other diarrheal pathogens have been linked 65 to pernicious sequelae of malnutrition, growth stunting, and impaired cognitive(12) 66 development. Presently, there are no vaccines to protect against these common infections. 67 ETEC are a genetically(13) and serotypically (14) diverse pathovar of E. coli defined by the 68 production of heat-labile (LT) and/or heat stable (ST) enterotoxins which activate production of 69 host cyclic nucleotides to alter intestinal salt and water transport that culminate in net fluid 70 losses and diarrhea. 71
Heat-stable toxins are synthesized as 72 amino acid proteins consisting of a signal peptide, a 72 pro peptide and a carboxy terminal region of 18-19 amino acids, which forms the mature active 73 enterotoxin (15) . Two enterotoxins cause disease in humans: STp (ST1a) 18 amino acids, and 74 STh (ST1b) 19 amino acids. Both mature toxins contain four cysteine residues which form two 75 intramolecular disulfide bonds. Their overall structure is shared with two homologous 76 mammalian peptides, guanylin and uroguanylin. Each of the bacterial and mammalian peptides 77 binds to guanylate cyclase C (16, 17) , leading to increases in intracellular cGMP (18) . Increases in this cyclic nucleotide result in activation of protein kinases which phosphorylate and activate 79 the cystic fibrosis transmembrane regulatory(CFTR) channel, and inhibit sodium-hydrogen ion 80 exchange (19) . These effects lead to a net loss of salt and water into the intestinal lumen with 81 ensuing watery diarrhea. 82
Bacteria producing any of the toxins LT, STh, or STp have been linked to diarrheal illness in 83 humans (20) (21) (22) (23) , and recent studies suggest that ST-producing ETEC are commonly represented 84 among the pathogens that cause severe diarrheal illness among young children in low income 85 countries leading to substantial interest in the development of a vaccine that incorporates . 87
Enterotoxigenic E. coli strain H10407, originally isolated from a case of severe cholera-like 88 diarrheal illness in Bangladesh, is to date the most extensively characterized isolate of this 89 pathovar. Interestingly, this isolate encodes all three enterotoxins associated with ETEC 90 diarrheal illness in humans (25, 26) , with the gene for STh on the largest 94,797 bp virulence 91 plasmid (NCBI Genbank acccession NC_017724.1), and the genes for both LT and STp on a 92 66681 bp plasmid (27) . H10407 is frequently used as the challenge strain in controlled human 93 infection models to test candidate vaccines. Therefore, we set out to examine the relative 94 contribution of STh and STp to activation of cGMP in host epithelia by H10407, and the ability 95 of anti-ST and anti-adhesin antibodies to mitigate effective toxin delivery by the bacteria. 96 97 98
Materials and methods 99
Bacterial strains and growth conditions 100 Bacterial strains used are listed in Table 1 . For general purposes, ETEC bacteria were grown in 101 lysogeny broth at 37°C overnight from frozen glycerol stocks. To optimize synthesis and 102 secretion of ST toxin, bacteria were grown in Casamino Acids-yeast extract -sucrose medium 103 (CAYE-ST) (2% Casamino acids, 0.6% Yeast extract, 43mM NaCl, 38mM K2HPO4, 203mM 104
MgSO4, 25mM MnCl2, 18mM FeCl3, 2% sucrose) at 37°C overnight from frozen glycerol stocks. 105
106
Construction of mutants lacking production and secretion of heat stable toxins 107 Lamda red recombinase mediated recombination(28) was used to disrupt genes encoding heat 108 stable toxins in H10407. In brief, we used the primers jf070212.1 and jf070212.2 to amplify the 109 kanamycin cassette from pKD13 with 36 bp overhang sequence from estH gene, and primers of 110 jf070212.3 and jf070212.4 to amplify kan cassatte from pKD13 with 36 bp overhang sequence 111 from estP gene. The PCR product was electroporated into competent H10407 containing helper 112 plasmid pKD46, and selected on LB plate with 50 µg/ml kanamycin. Kanamycin-resistant 113 colonies were screened by PCR with primers of jf071612.1 and jf071612.2 for the estH locus, and 114 primers of jf071612.3 and k2 for estP. The deletion mutants were further confirmed by toxin 115 multiplex PCR as previously described (29). 116
To construct complemented strains, we amplified the estP gene with primers jf072412.3 and 117 jf060614.1 for cloning into XhoI site of pBAD/mycHisA, yielding pSMD002; estH was amplified 118 with primers of jf072414.5 and jf072414.6 and cloned into the EcoRV site of pACYC184 to 119 produce pSMD001. We also cloned estH and estP genes individually and together in pETDuet-1 120 at NcoI & EcoRI sites and BglII & XhoI sites with primer pairs of jf060614.2 and jf060614.3, 121 jf060614.4 and jf060614.5, respectively. This resulted in plasmids pQL230 (estP), pQL231(estH), 122 and pQL238 (estP/estH) (table 1) . After confirmation by sequencing, the respective plasmids 123 were transformed into the deletion strains, and complementation confirmed by PCR. 124 To generate an ETEC tolC deletion mutant, primers jf110716.44 /45 were first used to amplify a 125 ∆tolC732:: Km R fragment from JQ55031(30). Next, the regions flanking tolC in the H10407 126 genome were amplified with primer pairs jf110716. 38/ jf110716.43 and jf110716.46/ jf110716.39 127 to amplify 1027 bp of upstream and 985 bp of downstream sequence, respectively. The three 128 resulting fragments were then fused by PCR with primer pairs jf110716.38/ jf110716.39, using 129 high-fidelity polymerase Phusion (Thermo Fisher Scientific), with denaturing for 2 min at 98°C, 130 followed by 30 cycles of 10 s at 98°C, 30 s at 65°C, and 1.5 min at 72°C, and a final extension for 131 10 min at 72°C. The resulting 3,325-bp amplicon was then introduced into H10407(pKD46) as 132 described above. Kanamycin resistant, Ampicillin sensitive colonies were then screened by 133 colony PCR using primer pair jf112016.50/51 flanking the entire amplicon for a 4269-bp product, 134 and primers jf101716.21/22 specific to tolC gene (603-bp product). Primers k2/jf112016.51 135
(2,024-bp product) were then used to confirm the tolC gene deletion and the Km R cassette 136 integration in the H10407 genome. To complement the tolC mutant, the tolC gene was 137 amplified from H10407 genomic DNA using primers jf120716.59/jf120716.60, and the plasmid 138 vector backbone was amplified from plasmid pBAD/myc-His B using primers 139 jf120716.52/jf120716.53. The recombinant pYZ008 complementation plasmid was assembled 140 using an adaptation of circular polymerase extension cloning (CPEC) (31) (30 s denaturation at 141 98°C, followed by 20 cycles of 10 s at 98°C, 30 s at 55°C, and 1.5 min at 72°C, and a final 142 extension for 10 min at 72°C.). Following sequence verification, pYZ008 or the pBAD/myc-His B 143 vector control plasmids were then used to transform the ΔtolC mutant. Complementation was 144 confirmed by PCR with primers jf101716.21/22.
FLAG-STH fusions 146
FLAG epitope fusions were constructed to introduce the 3X FLAG sequence between the signal 147 peptide of estH and the beginning of the propeptide encoding region (on plasmid pFLAG 3 -STH) 148 or at the 3' end of estH (on pSTH-FLAG 3 ). The 3X FLAG fragment was 1 st constructed by 149 annealing complementary synthetic oligonucleotides jf092616.9 encoding + strand bases 1-43 150 and jf092616.10 representing-strand bases 66-19 of a 66 base pair sequence encoding the 3x 151 FLAG peptide (DYKDHDGDYKDHDIDYKDDDDK). 152
To generate plasmid pFLAG 3 -STh where the 3xFLAG encoding sequence was inserted between 153 the STh signal peptide and the STh propeptide, primers jf101916.33/ jf092616.4 were first used 154 to amplify the nucleotides (1-63) of estH encoding the signal peptide. Next primers jf092616.1/ 155 jf092616.2 were used to amplify the 3xFLAG fragment from the above synthetic 156 oligonucleotide 3XFLAG template flanked by nucleotide extensions representing nucleotides 157 44-60 and 64-99 of estH, while primers jf092616.3/ jf101916.34 were used to amplify the 3' end 158 of estH from nucleotide 64 to the native stop codon. The three fragments were fused in a single 159 PCR reaction using primers jf101916.33/jf101916.34. Next, the vector backbone was amplified 160 using primers jf101916.31/ jf101916.32 from pFLAG-CTC (Sigma), followed by final assembly of 161 pFLAG 3 -STh by CPEC. Similarly, to make plasmid pSTh-FLAG 3 primers jf092616.5/ jf101916.35 162 were used to amplify 3XFLAG with a 5' nucleotide extension representing nucleotides 197-216 163 of estH, while primers jf101916.33/jf092616.8 were used to amplify the estH gene with a 5' 164 nucleotide extension corresponding to pFLAG-CTC. The resulting amplicons were then fused in 165 a single PCR reaction using primers jf101916.33/ jf101916.35, and assembled with the pFLAG-166 CTC backbone by CPEC. 167
Cloning, expression, and purification of recombinant ST proteins peptides 169
To construct a GST-STh or mutant GST-mSTh (A14Q) expression plasmid, synthetic 170 oligonucleotides were synthesized (IDT, Coralville, Iowa) which encompassed the region of the 171 estH gene corresponding to the mature peptide minus the native start codon, preceded by an 172 in-frame flexible linker sequence (32). The forward sequence (jf042715.1 for STh and jf042517.1 173 for mSTh), preceded by a BamHI overhang sequence (GATCC) and the reverse sequence 174 (jf042715.2 for STh and jf042517.2 for mSTh), preceded by an EcoRI overhang sequence 175 (AATTC) were mixed in 1:1 molar ratio, heated to 95° C for 5 minutes, and cooled to room 176 temperate. The annealed double stranded 91 base pair DNA fragments were then cloned 177 directly into the pGEX-4T1 vector digested with BamHI and EcoRI, yielding plasmids pCW002 178 and pYZ011, respectively. A similar strategy was to construct a GST-STp expression plasmid 179 using forward oligonucleotide jf031915.5 and the reverse sequence jf031915.6, resulting in 180 plasmid pCW003. E. coli TOP10(pCW002), TOP10(pCW003), and TOP10(pYZ011) were then 181 used to express recombinant GST-STh, GST-STp, or GST-mSTh, and the resulting fusion 182 proteins were purified by affinity chromatography. In brief, the bacterial cultures were grown in 183 Luria broth at 37°C to an OD 600 between 0.6 and 0.7, and induced with 1 mM IPTG final 184 concentration for 1-3 hours. The cell pellets were re-suspended in 30 ml cold PBS containing 5 185 mM DTT, 1 protease inhibitor tablet (Roche), and 0.1 mg/ml lysozyme. Following sonication, 186 supernatants were clarified by centrifugation at 12,000 rpm for 20 minutes at 4°C, followed by 187 passage through a 0.45 µm filter. Filtered supernatants were then loaded onto columns 188 (Glutathione Sepharose High Performance, GE Healthcare) pre-equilibrated with phosphate 189 buffered saline (PBS), pH 7.3 (140 mM NaCl, 2.7 mM KCl,10 mM Na2 HPO4, 1.8 mM KH 2 PO4, 190 pH 7.3). After washing with 20 column volumes of PBS containing 1 mM dithiothreitol (DTT), GST fusion proteins were eluted in fresh buffer containing (100 mM Tris-HCl, pH 8.0 and 10 mM 192 reduced glutathione), and dialyzed against PBS. 193 194 To liberate native STh or mutant STh (mSTh) from its GST fusion partner, GST-fusion protein 195 was dialyzed in 50 mM NH 4 HCO 3 (pH 8.5), containing 1 unit of thrombin (Sigma) per mg fusion protein at 4°C overnight, centrifuged at 4000 x g for 20 minutes a 10 kDa MWCO 197 centrifugal filter to collect the filtrate, and dried by vacuum centrifugation. Peptide Primers specific to arcA, estH, estP, or tolC gene are listed in Table 2 . All transcripts were 211 normalized to arcA, and presented as a ratio of transcripts in adherent bacteria relative to that 212 of planktonic bacteria. 213
Production and purification of anti-ST polyclonal antibody 214
To generate rabbit polyclonal antibody which recognizes ST-H, New Zealand white rabbits 215 AAEC191A (33), and an immobilized E. coli lysate column (Pierce 44938) to absorb E. coli-217 reactive antibodies, followed by protein G column purification (HiTrap, GE 17-0404-01). IgG 218 GST-ST-H antibodies were affinity purified using GST-STh immobilized on nitrocellulose as 219 previously described and anti-GST-reactive antibodies were removed by cross-absorption 220 against GST coupled to Glutathione Agarose Resin (Gold Bio G-250-100, St. Louis). 221
Anti-STp antibody, was purified from rabbit antisera (provided by Weiping Zhang, Kansas State 222 University) by cross-absorption against an immobilized E. coli lysate column and then followed 223 by affinity purification against recombinant GST-STp) immobilized on nitrocellulose 224 membranes for affinity purification. 225
Immunoprecipitation and detection of heat-stable toxins in culture supernatants 226
Purified anti-STh polyclonal IgG was immobilized with AminoLink Plus Coupling Resin (Pierce 227 Direct IP kit Thermo Scientific, 26148). Clarified culture supernatants of overnight cultures of 228 ETEC were mixed with protease inhibitor cocktail (ThermoFisher 88666), and filtered through a 229 0.45 µm filter. Sixty ml of supernatant was then filtered through 10 kDa molecular weight cutoff 230 membrane (Amicon). Filtrates were then dried by vacuum centrifugation, and dialyzed in PBS 231 against a 1 kDa-cutoff membrane (Float-A-Lyzer G2, MWCO 0.5-1 kDa, Spectrum Labs). 232
Immunoprecipitations were conducted by incubation of filtrates with anti-STh immobilized 233 resin for 2 hours at room temperature followed by elution with 4.5% acetic acid. Eluates were 234 dried by under vacuum centrifugation, and reconstituted in PBS. Immunoprecipitated samples 235 or purified protein/peptide as controls were applied directly to 0.22 µm pore-size PVDF 236 membranes (Bio-Rad), and detected by anti-STh and/or anti-STp primary antibody and anti-237
Rabbit-HRP conjugated secondary antibody using Clarity Western ECL Substrate (Bio-Rad). 238 FLAG-STh fusion peptides were prepared from strain jf2847 carrying pFLAG 3 -STh, pSTh-FLAG 3 , 239 or the blank vector pFLAG-CTC. Briefly, following overnight growth at 37°C in lysogeny broth containing ampicillin (100 µg/ml), cultures were diluted 1:100 in fresh media, grown to OD 600 of 241 ~0.2, then induced with 1 mM IPTG for 7 h. 40 ml of clarified supernatant was mixed with 200 µl 242 of anti-FLAG (M2) affinity gel (#A2220, Sigma), then incubated overnight at 4°C with agitation. 243
After washing with TBS buffer, bound proteins were eluted with 0.1M glycine-HCl, pH 3.5, 244 separated by SDS-PAGE, transferred to nitrocellulose for subsequent immunoblotting, and 245 detected by anti-FLAG antibody (#F1804, Sigma). 246
Confocal immunofluorescence imaging and quantification 247
To examine the delivery of FLAG-tagged STh toxin to intestinal epithelial cells, estP/estH 248 mutant strains with or without plasmids encoding FLAG-tagged STh were grown overnight and 249 diluted 1:50 in CAYE-ST medium, grown to OD 600 of ~0.2, then induced with 1 mM IPTG for 2 h. 250
The bacteria were added to T84 cells at a multiplicity of infection (MOI) of ~1:50, maintaining 251 the induction with 1 mM IPTG. After infection with the bacteria, T84 cells were washed with 252 PBS, fixed with 4% paraformaldehyde for 10 min at room temperature, permeabilized with 253 0.1% TRITON X-100 for 5 min, blocked with 1.5% BSA/PBS at 37°C for 1 h. Anti-O78 rabbit 254 polyclonal antisera (Penn State University) diluted 1:300 in PBS with 0.02% Tween-20 (PBST) 255 and 1.5% BSA was used to identify H10407 and monoclonal Anti-FLAG M2 antibody (#F1804, 256 Sigma) diluted 1:500 in PBST with 1.5% BSA to detect FLAG-tagged STh. Following incubation 257 overnight at 4°C, slides were washed 3x with PBS, and incubated for 1 hour at 37°C with goat-258 anti rabbit IgG (H&L) AlexaFluor-488 conjugate (ThermoFisher A11070) and goat-anti mouse 259 IgG (H&L) conjugated to AlexaFluor 594 (ThermoFisher A11032) at a dilution of 1:500 in PBST 260 containing 1.5% BSA. After washing, DAPI (4', 6-diamidino-2-phenylindole) was added at 1: 261 6,000. Confocal microscopy images were acquired using a Nikon C2+ Confocal Microscope 262 System. To quantitate binding of FLAG-epitope tagged STh molecules, fluorescence detection 263 was normalized to the DAPI signal using NIS-Elements DUO software (v4.4).
In vitro assessment of toxin delivery 265
T84 (ATCC® CCL-248™) intestinal epithelial cells were maintained in DMEM/F12 (1:1) medium 266 containing FBS (5% [vol/vol]). T84 cell monolayers were grown in 96 well plates for 24-48 hours 267 at 37°C, 5% CO2 incubator, to > 90% confluency. Cultures of bacteria were grown overnight in 268 lysogeny broth from frozen glycerol stocks in CAYE-ST medium. Phosphodiesterase inhibitors 269 vardenafil hydrochloride trihydrate (#Y0001647), rolipram (#R6520), and cilostazol (#C0737) 270 (all from Sigma-Aldrich), were each added to target T84 cells at a final concentration of 16.7 or 271 50 µM and incubated with cells for one hour. Bacteria or toxin were added to T84 monolayers 272 seeded into 96-well plates and continued the treatment for the indicated duration. After 273 washing in PBS cyclic GMP (cGMP) levels were determined by enzyme immunoassay (EIA) 274 (Arbor Assays, K020-H1) using the acetylated protocol as directed by the manufacturer. 275
To examine the capacity of antibodies to neutralize ST delivery, antibody against EtpA was added directly to T84 cell monolayers at the indicated dilution at the time of 277 infection. After 1.5 hours, cells were washed by PBS, and lysed, and cGMP assays were 278 performed as described above. NC_017724.1). The astA gene which encodes EAST1 peptide (35) is imbedded within a IS1414 288 insertion sequence(36) is also located on the p948 plasmid immediately downstream from the etpBAC adhesin locus (27, 37) . ST-P (ST-1a) is encoded by the estP gene on a second 66 kb 290 virulence plasmid NCBI GenBank FN649417.1 in H10407. 291
We found that deletion of estH resulted in appreciable decreases in cGMP production at or near 292 background levels of cGMP production by uninfected cells, and that complementation of estH 293 in trans restored activation of this cyclic nucleotide ( Figure 1A) . In contrast, the estP mutant was 294 not appreciably different than the wild type strain, and the introduction of the estP mutation to 295 the estH strain did not yield further measurable decreases in cGMP production by target 296 epithelial cells. However, we found that the target T84 cells used in these assays did respond to 297 GST fusions to either ST-H or ST-P ( Figure 1B) suggesting that these cells have the capacity to 298 respond to either peptide. Interestingly, we found that in contrast to estH, estP transcription 299 was significantly influenced by bacterial cell contact with transcription of the gene encoding 300 ST-P enhanced by bacterial adhesion, as was the tolC gene which encodes the putative export 301 channel for ST ( Figure 1C ). Deletion of astA gene encoding EAST on the p948 plasmid did not 302 impact bacterial activation of cellular cGMP under the conditions of the assay ( Figure 1D) . 303 304 TolC is required for effective ETEC secretion of ST1 toxins 305
The precise mechanism for secretion of heat stable toxins from ETEC strains associated with 306 disease in humans is presently uncertain. Prior studies of heat-stable toxin investigated the 307 secretion STb(ST-II)(38), or STp(STIa)(39) from laboratory strains of E. coli containing 308 recombinant expression plasmids. While both studies suggested that the outer membrane 309 protein TolC is involved in secreting these toxins from the recombinant E. coli background, 310 there is conflicting data regarding the involvement of the STb (STII) toxin in human disease (40, 311 41) , and unlike the ST1 toxins, STb does not bind to guanylate cyclase C. Similarly, to our 312 knowledge, there has been no verification of the role of tolC in mediating the secretion of either of the ST1 toxins (STh and STp) from strains of ETEC isolated from humans. Therefore, to verify 314 the importance of the TolC in secretion of both STh (ST1b) and STp(ST1a) from ETEC which 315 cause human illness, we constructed an isogenic tolC mutant in the ETEC H10407 strain, and 316 tested the ability of the mutant bacteria to deliver ST to target epithelial cells. 317
We found that mutants lacking tolC were markedly deficient in their ability to deliver ST toxins 318 to epithelial monolayers as we observed only background levels of cGMP production following 319 infection with the tolC mutant strain, and complementation with tolC in trans restored the 320 ability of the bacteria to provoke a cGMP response in targeted cells (Figure 2) . 321
Optimal delivery of ST requires the EtpA adhesin. 322
We have previously demonstrated that intimate interaction of ETEC with intestinal epithelial 323 cells is essential for efficient delivery of heat labile toxin to intestinal epithelial cells(42). 324
Moreover, delivery of LT requires the concerted action of several ETEC adhesins with different 325 receptor specificities. To examine the dependence of ST delivery on bacterial adhesion we 326 compared cGMP activation of target intestinal epithelial cells by wild type ETEC to a mutant 327 strain lacking EtpA, a plasmid-encoded adhesin, expressed by a diverse population of ETEC (43) . 328
These studies demonstrated that cGMP activation in target epithelia by wild type bacteria was 329 significantly accelerated relative to the etpA mutant ( Figure 3) suggesting that efficient delivery 330 of these small peptides also requires effective bacterial-host interactions. 331
Anti-toxin and anti-adhesin antibodies mitigate delivery of heat-stable toxins 332
ETEC delivery of heat labile toxin can be effectively blocked by antibodies directed against 333 either LT or the EtpA adhesin molecule(44). These data suggest that anti-adhesin and anti-334 toxin strategies could provide complementary approaches to vaccine development. The etpA 335 gene, like those encoding LT, and ST1 molecules appears to be highly conserved within the 336 ETEC pathovar(43). Therefore, we examined the ability of antibodies against the EtpA adhesin 337 to inhibit activation of cGMP in target intestinal cells. 338
Antibodies directed against either the EtpA adhesin molecule or STh significantly inhibited the 339 delivery of heat-stable toxins to target cells (Figure 4 ). Although we were not able to 340 demonstrate that the combination of these antibodies was synergistic, these data add 341 additional support to the concept that EtpA could be useful as a target to engender coverage 342 against a wide variety of ETEC isolates that produce heat-stable and/or heat-labile 343 enterotoxins (43, 45) . 344
Delivery and secretion of epitope-tagged ST-H 345
Understanding the nature of ST secretion and its delivery to epithelial receptors could be 346 relevant to informed development of ST toxoid molecules. ST-H is synthesized as a 72 amino 347 acid molecule that includes a 19 amino acid signal peptide, followed by a 34 amino acid pro-348 peptide, and a mature ST molecule of 19 amino acids. Although most attempts to develop ST 349 toxoids have targeted the mature peptides, there are earlier, but conflicting data regarding the 350 precise form of ST that is secreted into the extracellular milieu (15, 46), with some data 351 suggesting that the pro-peptide may be exported with subsequent processing to the mature 352 peptide outside the bacteria (47). To investigate the potential secretion of the pro-peptide, we 353 engineered 3x-FLAG-epitope fusions to the amino terminal end of the pro-peptide region 354 (FLAG 3 -pro-ST-H) of ST-H and compared the export, and delivery of the resulting peptides to 355 carboxy-terminal fusions to the mature peptide (pro-ST-H-FLAG 3 , schematic, figure 5). 356
We were able to recover either the amino-terminal or carboxy-terminal FLAG-tagged 357 molecules from culture supernatants of estH/estP mutant ETEC transformed with the pST-358 FLAG 3 or pFLAG 3 -STH plasmids, respectively (figure 5a). Both molecules appeared to yield 359 functional ST mature peptides as either plasmid was sufficient to complement the ability of 360 estH/estP to activate cGMP in target epithelial cells (figure 5b). Likewise, we were able to demonstrate binding of FLAG-epitope tagged molecules to target epithelial cells following 362 infection with either of the complemented strains ( figure 5c, d) . Collectively, these data appear 363 to reaffirm earlier observations of STA3 (ST-H)(47) suggesting that both the mature form (19 364 amino acids) of the peptide and the extended Pro-ST-H (53 amino acids) may be found outside 365 the bacteria. 366 367 Discussion 369
Because of the significant global burden of diarrheal illness caused by ETEC, these pathogens 370 have been a target for vaccine development since they were first identified as a cause of severe 371 diarrheal illness more than four decades ago. Currently, there is no vaccine available that 372 affords broad-based protection against ETEC, in part due the substantial antigenic diversity 373 within the pathovar, and limited mechanistic insight into immunologic correlates of protection 374 that appears to follow early infections among young children endemic areas. Moreover, many 375 features of the molecular pathogenesis of these common pathogens have not been explored in 376 sufficient detail to inform vaccine development. 377
Because ST-producing ETEC comprise a large proportion of strains associated with 378 symptomatic diarrheal illness(48), we investigated the molecular contributions of the known 379 heat-stable toxins, their proposed secretion apparatus, and bacterial adhesion to toxin delivery. 380
The present studies suggest that efficient delivery of ST toxins is a complex process that 381 requires the ability to directly engage host cells and at least transient adhesion afforded by 382
EtpA and other adhesins(49). Moreover, as antibodies directed at either the EtpA adhesin or ST 383 effectively impaired toxin delivery, our studies provide further support for development of a 384 vaccine platform that combines ST-toxoid(24) and anti-adhesin approaches. 385
Interestingly, clinical studies have suggested that either ST-H originally identified in humans 386 and ST-P can cause diarrheal illness in humans(23). In keeping with these observations, we 387 found no difference in the ability of ST-H or ST-P peptides to elicit cGMP activation (18) Earlier studies also noted that many ETEC strains including H10407 bear copies of an insertion 395 sequence(36) that encompass the astA gene encoding EAST1(35), a cGMP activating peptide 396 structurally similar to ST1 that was originally identified as a heat-stable enterotoxin in 397 enteroaggregative E. coli (34) . However, we saw no appreciable decrease in cGMP in target 398 epithelial cells following infection with the astA mutant, compared to wild type ETEC. We 399 cannot rule out the possibility of EAST1 expression from additional copies of astA not residing 400 on the 92 MDa virulence plasmid, or that EAST1 is not optimally expressed in vitro. However, 401 the complete absence of a cGMP response in cells infected with the ST-1a/ST-1b deletion 402 mutant might alternatively suggest that EAST1 does not contribute to ETEC virulence and that 403 further toxoid vaccine development can simply focus on engendering neutralizing antibody 404 responses to the established ST1 and LT enterotoxins. 405
The reaffirmation of TolC as a key mechanism for export of ST1 toxins could be relevant to 406 management of diarrheal illness. The rapid emergence of multi-drug resistance in the 407 Enterobacteriaciae that is in part dependent on drug efflux through TolC has stimulated 408 interest in efflux inhibitors to enhance the potency of available antimicrobial agents(50-52). 409
Theoretically, these inhibitors could offer novel therapeutic agents for treatment of ETEC. 410
Our studies also revisit the concept that the larger pro-peptide form of ST-H may be exported 411 by the bacteria, and the data presented here are consistent with prior observations suggesting 412 that some processing of the pro-peptide occurs outside the bacteria (15, 47) . Further study will 413 be needed however to determine whether the pro-peptide sequence contributes to 414 immunologic recognition of ST following infection and whether these larger molecules might 415 be exploited in the development of improved toxoids to neutralize ST. 416 A. Immunoblot detection of ST1 toxins in culture supernatants of the wild type H10407 strain, 436 tolC mutant, or estH/estP dual deletion mutant following immunoprecipitation of culture 437 supernatants with affinity-purified anti-STh antibodies (IP α-STh). BSA and GST-STh fusion are 438 shown as negative and positive controls, respectively. B. cGMP production by T84 target 439 epithelial cells following infection with wild type (wt) ETEC strain H10407 (ST1a, ST1b), the tolC 440 mutant, the vector complemented mutant (pBAD-Myc-HisB) or the tolC-complemented 441 mutant (pZY008). 442 
